The Lancet. Oncology

Keyphrases

Publications

volume 24, number 6, 2023

Susu Yan, Twalib A Ngoma, Wilfred Ngwa, Thomas R Bortfeld
Global democratisation of proton radiotherapy. The Lancet. Oncology 24 (6) (2023)
Tian Chu, Yifan Meng, Ping Wu, Zheng Li, Hao Wen, Fang Ren, Dongling Zou, Huaiwu Lu, Lingying Wu, Shengtao Zhou, Ying Chen, Jundong Li, Miaochun Xu, Xiaoliu Wu, Xi Xiong, Zhibin Wang, Misi He, Yuanyuan Zhang, Shitong Lin, Canhui Cao, Wencheng Ding, Yu Chen, Wenhua Zhi, Ting Peng, Ye Wei, Binghan Liu, Yashi Xu, Ding Ma, Jing Wang, Chaoyang Sun, Peng Wu
The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry. The Lancet. Oncology 24 (6) (2023)
Angeline Sapiano, Clifford Caruana, Neville Spiteri, Andre Stefan Gatt, Sarah Degiorgio, Anthony Samuel, David Pisani, Malcolm Buhagiar
Extraskeletal osteosarcoma of primary retroperitoneal origin. The Lancet. Oncology 24 (6) (2023)
Kang Zou, Muhan Lü, Yan Peng, Xiaowei Tang
Artifical intelligence-based model for lymph node metastases detection in bladder cancer. The Lancet. Oncology 24 (6) (2023)

volume 24, number 7, 2023

Claire L Vale, David J Fisher, Peter J Godolphin, Larysa H Rydzewska, Jean-Marie Boher, Sarah Burdett, Yu-Hui Chen, Noel W Clarke, Karim Fizazi, Gwenaelle Gravis, Nicholas D James, Glenn Liu, David Matheson, Laura Murphy, Robert E Oldroyd, Mahesh K B Parmar, Ewelina Rogozinska, Patrick Sfumato, Christopher J Sweeney, Matthew R Sydes, Bertrand Tombal, Ian R White, Jayne F Tierney, null null
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials. The Lancet. Oncology 24 (7) (2023)
James Tankel, Sheraz Markar, Marc van Berge Henegouwen, Lorenzo Ferri, Jonathan Cools-Lartigue
Endoscopic surveillance in hereditary diffuse gastric cancer. The Lancet. Oncology 24 (7) (2023)
Linda R Mileshkin, Kailash Narayan, David K Gaffney, Elizabeth H Barnes, Yeh Chen Lee, Bradley J Monk, Martin R Stockler
Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply. The Lancet. Oncology 24 (7) (2023)
null The Lancet Oncology
Meeting the need for germline testing. The Lancet. Oncology 24 (7) (2023)
A Leila Sarvestani, Bilal Asif, Amber L Famiglietti, Louis Korman, Theo Heller, Jeremy L Davis
Endoscopic surveillance in hereditary diffuse gastric cancer - Authors' reply. The Lancet. Oncology 24 (7) (2023)
Dominique Levêque, Marine Beck, Mathieu Cotton
Dispensation for access to novel anticancer agents in France. The Lancet. Oncology 24 (7) (2023)
Kaso Ari, Sri Sivarajan, Jay J Park, Suheelan Kulasegaran, Bhaskar Kumar
Endoscopic surveillance in hereditary diffuse gastric cancer. The Lancet. Oncology 24 (7) (2023)
Meletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, Nelson Leung, Joseph Mikhael, Simon J Harrison, Efstathios Kastritis, Laurent Garderet, Alessandro Gozzetti, Niels W C J van de Donk, Katja C Weisel, Ashraf Z Badros, Meral Beksac, Jens Hillengass, Mohamad Mohty, P Joy Ho, Ioannis Ntanasis-Stathopoulos, Maria-Victoria Mateos, Paul Richardson, Joan Blade, Philippe Moreau, Jesus San-Miguel, Nikhil Munshi, S Vincent Rajkumar, Brian G M Durie, Heinz Ludwig, Evangelos Terpos, null null
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group. The Lancet. Oncology 24 (7) (2023)
Joseph Lubega, Lulu Chirande, Barnabas Atwine, Alan Davidson, Heronima J Kashaigili, Aimable Kanyamuhunga, Robert K Langat, Deogratias Munube, Rizine Mzikamanda, Ruth Namazzi, Irene Nzamu, Anne Akullo, Carl Allen, Julie M Gastier-Foster, Marilyn Hockenberry, Nmazuo Ozuah, Peter Wasswa, Rachel Smith, Kristi Wilson-Lewis, David G Poplack
Addressing the childhood cancer crisis in sub-Saharan Africa. The Lancet. Oncology 24 (7) (2023)
Massimiliano di Pietro, Judith Honing, Colin Yc Lee, Rebecca C Fitzgerald
Endoscopic surveillance in hereditary diffuse gastric cancer. The Lancet. Oncology 24 (7) (2023)
B Jayakrishnan, Ikram Burney, Anjum Hassan Osman, Sami M Bennji, Zamzam Al-Hashami
Adenocarcinoma of lung presenting as diffuse interstitial lung disease. The Lancet. Oncology 24 (7) (2023)
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, Simone Koole, Lonneke Timmers, Christian Blank, Hans Gelderblom
Adjuvant immune checkpoint blockade revisited. The Lancet. Oncology 24 (7) (2023)
Alberto Mussetti, Anna Sureda
γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cells. The Lancet. Oncology 24 (7) (2023)
Sezin Yuce Sari, Nur Nimet Saliha Akdag, Melis Gultekin, Ferah Yildiz
Adjuvant chemotherapy for locally advanced cervical cancer. The Lancet. Oncology 24 (7) (2023)
Andrew J Cowan, Margot J Pont, Blythe D Sather, Cameron J Turtle, Brian G Till, Edward N Libby, David G Coffey, Sherilyn A Tuazon, Brent Wood, Ted Gooley, Vicky Q Wu, Jenna Voutsinas, Xiaoling Song, Mazyar Shadman, Jordan Gauthier, Aude G Chapuis, Filippo Milano, David G Maloney, Stanley R Riddell, Damian J Green
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. The Lancet. Oncology 24 (7) (2023)
Alessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, Luca Viganò, David J Pinato, Francesca Romana Ponziani, Quirino Lai, Andrea Casadei-Gardini, Ciro Celsa, Giovanni Galati, Martina Gambato, Laura Crocetti, Matteo Renzulli, Edoardo G Giannini, Fabio Farinati, Franco Trevisani, Umberto Cillo, null null
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. The Lancet. Oncology 24 (7) (2023)

volume 24, number 8, 2023

Nereo Segnan, Antonio Ponti
Artificial intelligence for breast cancer screening: breathtaking results and a word of caution. The Lancet. Oncology 24 (8) (2023)
Julie S Townsend
2020 cancer incidence data in the USA reveal effects of the COVID-19 pandemic. The Lancet. Oncology 24 (8) (2023)
null The Lancet Oncology
Climate change and skin cancer: urgent call for action. The Lancet. Oncology 24 (8) (2023)
Riccardo Nocini, Luca Tondulli, Consuelo D'Ambrosio, Claudio Luchini, Andrew V Biankin, Raffaella Casolino, Aldo Scarpa, null null, Michele Milella, Rita T Lawlor
ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma. The Lancet. Oncology 24 (8) (2023)
Xuesong Han, Nuo Nova Yang, Leticia Nogueira, Changchuan Jiang, Nikita Sandeep Wagle, Jingxuan Zhao, Kewei Sylvia Shi, Qinjin Fan, Elizabeth Schafer, K Robin Yabroff, Ahmedin Jemal
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment. The Lancet. Oncology 24 (8) (2023)
Gary Rodin, Mac Skelton, Nirmala Bhoo-Pathy, Omar Dewachi, Madeline Li, Dario Trapani, Elizabeth Smyth, Matthew Banegas, Naveen Salins, Karla Unger-Saldaña, Camilla Zimmermann, Richard Sullivan
Establishing a Lancet Oncology Commission on the humanitarian crisis of cancer. The Lancet. Oncology 24 (8) (2023)
Arthur Accioly Rosa, Cecília Félix Penido Mendes de Sousa, Leonardo Cunha Furbino Pimentel, Homero Lavieri Martins, Fabio Ynoe Moraes, Gustavo Nader Marta, Marcus Simões Castilho
Radiotherapy resources in Brazil (RT2030): a comprehensive analysis and projections for 2030. The Lancet. Oncology 24 (8) (2023)
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, Nandita M deSouza, David Krug, Laurence Collette, Wolfgang Kunz, Yazid Belkacemi, Maria Grazia Bau, Caroline Caramella, Lioe-Fee De Geus-Oei, Alex De Caluwé, Christophe Deroose, Olivier Gheysens, Ken Herrmann, Isabelle Kindts, Michalis Kontos, Sherko Kümmel, Barbro Linderholm, Egesta Lopci, Icro Meattini, Ann Smeets, Orit Kaidar-Person, Philip Poortmans, Pelagia Tsoutsou, Nawale Hajjaji, Nicola Russell, Elżbieta Senkus, Jean-Noël Talbot, Lale Umutlu, Vincent Vandecaveye, Joost J C Verhoeff, Willemien Menke-van der Houven van Oordt, Helle D Zacho, Fatima Cardoso, Laure Fournier, Frederieke Van Duijnhoven, Frédéric E Lecouvet
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups. The Lancet. Oncology 24 (8) (2023)
Rahul Jena, Rami Issa, Matthew Perry
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed. The Lancet. Oncology 24 (8) (2023)
Shubham Pant, Martin Schuler, Gopa Iyer, Olaf Witt, Toshihiko Doi, Shukui Qin, Josep Tabernero, David A Reardon, Christophe Massard, Anna Minchom, Iwona Lugowska, Omar Carranza, Dirk Arnold, Martin Gutierrez, Helen Winter, Kim Stuyckens, Lauren Crow, Saltanat Najmi, Constance Hammond, Shibu Thomas, Ademi Santiago-Walker, Spyros Triantos, Hussein Sweiti, Yohann Loriot, null null
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study. The Lancet. Oncology 24 (8) (2023)
Alexandre R Zlotta, Katherine Lajkosz, Jason A Efstathiou
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed - Authors' reply. The Lancet. Oncology 24 (8) (2023)
Kevin E Shopsowitz, Xiu Qing Wang, Maryam Soleimani, Monika Hudoba, Luke Y C Chen, Eric McGinnis
Metastatic seminoma masquerading as sarcoidosis. The Lancet. Oncology 24 (8) (2023)
Michelle M Kim, Minesh P Mehta, DeeDee K Smart, Patricia S Steeg, Julie A Hong, Michael G Espey, Pataje G Prasanna, Laura Crandon, Christine Hodgdon, Niki Kozak, Terri S Armstrong, Aki Morikawa, Nicole Willmarth, Kirk Tanner, Adrienne Boire, Melanie Hayden Gephart, Kim A Margolin, Jona Hattangadi-Gluth, Hussein Tawbi, Daniel M Trifiletti, Caroline Chung, Upal Basu-Roy, Robyn Burns, Isabella C Glitza Oliva, Ayal A Aizer, Carey K Anders, Joanne Davis, Manmeet S Ahluwalia, Veronica Chiang, Jing Li, Rupesh Kotecha, Silvia C Formenti, Benjamin M Ellingson, Vinai Gondi, Paul W Sperduto, Jill S Barnholtz-Sloan, Jordi Rodon, Eudocia Q Lee, Mustafa Khasraw, Debra Nana Yeboa, Priscilla K Brastianos, Evanthia Galanis, C Norman Coleman, Mansoor M Ahmed
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. The Lancet. Oncology 24 (8) (2023)
Kristina Lång, Viktoria Josefsson, Anna-Maria Larsson, Stefan Larsson, Charlotte Högberg, Hanna Sartor, Solveig Hofvind, Ingvar Andersson, Aldana Rosso
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. The Lancet. Oncology 24 (8) (2023)

volume 24, number 9, 2023

Claire Petit, Jean-Pierre Pignon, Pierre Blanchard
Incorporating absolute effects to enrich interpretation of findings from meta-analyses - Authors' reply. The Lancet. Oncology 24 (9) (2023)
Mark P Lythgoe, Richard Sullivan, Sarah Blagden
UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver new anti-cancer therapies. The Lancet. Oncology 24 (9) (2023)
Masakazu Toi, Tomoyuki Aruga
SERDs for primary breast cancer. The Lancet. Oncology 24 (9) (2023)
Allan Cramer, Freja K H Sørup, Hanne R Christensen, Tonny S Petersen, Kristian Karstoft
Withdrawn accelerated approvals for cancer indications in the USA: what is the marketing authorisation status in the EU? The Lancet. Oncology 24 (9) (2023)
Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau, Li Zhang, Janusz Milanowski, Manuel Cobo, Jaromir Roubec, Lubos Petruzelka, Libor Havel, Sujith Kalmadi, Jeffrey Ward, Zoran Andric, Thierry Berghmans, David E Gerber, Goetz Kloecker, Rajiv Panikkar, Joachim Aerts, Angelo Delmonte, Miklos Pless, Richard Greil, Christian Rolfo, Wallace Akerley, Michael Eaton, Mussawar Iqbal, Corey Langer, null null
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study. The Lancet. Oncology 24 (9) (2023)
Binghe Xu
Dalpiciclib in advanced breast cancer: introducing CDK4/6 inhibitors as a first-line treatment might not be the best strategy - Author's reply. The Lancet. Oncology 24 (9) (2023)
May Elbanna, Yaroslav Pynda, Oleksandr Kalinchuk, Arthur Rosa, May Abdel-Wahab
Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data. The Lancet. Oncology 24 (9) (2023)
Joshua D Bernstock, Alexander Ling, E Antonio Chiocca
Combined gene therapies for high-grade glioma. The Lancet. Oncology 24 (9) (2023)
Yoshie Umemura, Daniel Orringer, Larry Junck, Maria L Varela, Molly E J West, Syed M Faisal, Andrea Comba, Jason Heth, Oren Sagher, Denise Leung, Aaron Mammoser, Shawn Hervey-Jumper, Daniel Zamler, Viveka N Yadav, Patrick Dunn, Wajd Al-Holou, Todd Hollon, Michelle M Kim, Daniel R Wahl, Sandra Camelo-Piragua, Andrew P Lieberman, Sriram Venneti, Paul McKeever, Theodore Lawrence, Ryo Kurokawa, Karen Sagher, David Altshuler, Lili Zhao, Karin Muraszko, Maria G Castro, Pedro R Lowenstein
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial. The Lancet. Oncology 24 (9) (2023)
null The Lancet Oncology
Avoidable mortality in the UK unlikely to change soon. The Lancet. Oncology 24 (9) (2023)
Elif Hindié
Dalpiciclib in advanced breast cancer: introducing CDK4/6 inhibitors as a first-line treatment might not be the best strategy. The Lancet. Oncology 24 (9) (2023)
Kellie Alleyne-Mike
Gauging radiotherapy resources in South America and the Caribbean. The Lancet. Oncology 24 (9) (2023)
Julie Ritter, Savannah Allen, Phillip D Cohen, Andrés Felipe Fajardo, Kelsey Marx, Patrícia Loggetto, Carmen Auste, Hedley Lewis, Karla Emília de Sá Rodrigues, Sharmeen Hussain, Ayomide Omotola, Nancy S Bolous, Harsha Thirumurthy, Beverley M Essue, Eva Steliarova-Foucher, I-Chan Huang, Filip Meheus, Nickhill Bhakta
Financial hardship in families of children or adolescents with cancer: a systematic literature review. The Lancet. Oncology 24 (9) (2023)
Sara A Hurvitz, Aditya Bardia, Vanesa Quiroga, Yeon Hee Park, Isabel Blancas, José Luis Alonso-Romero, Aleksandr Vasiliev, Hryhoriy Adamchuk, Marcelo Salgado, Denise A Yardley, Oleksandr Berzoy, Pilar Zamora-Auñón, David Chan, Gonzalo Spera, Cloris Xue, Erika Ferreira, Tanja Badovinac Crnjevic, Pablo Diego Pérez-Moreno, Vanesa López-Valverde, Jutta Steinseifer, Tharu M Fernando, Heather M Moore, Peter A Fasching, null null
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study. The Lancet. Oncology 24 (9) (2023)
Dean A Fennell
Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer. The Lancet. Oncology 24 (9) (2023)
Jing Wu, Shitong Xie, Xiaoning He, Tianqi Hong, Liang Yao
Incorporating absolute effects to enrich interpretation of findings from meta-analyses. The Lancet. Oncology 24 (9) (2023)